Industry Focus
Healthcare: Money-School Lessons On Biosimilars and Cash Burn
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:52
- Mas informaciones
Informações:
Sinopsis
Revealing the difference between small molecule drugs and biologics and illustrating why cash and equivalents is the most important line item on biotech balance sheets.
